Debiopharm Group (Debiopharm)

Oncology Corporate Profile

HQ Location

Chemin Messidor 5-7
CH - 1002 Lausanne, Switzerland 5911

Company Description

Debiopharm Group™ (Debiopharm) is a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. The group in-licenses, develops and/or co-develops promising biological and small molecule drug candidates having reached clinical development phases I, II or III. Debiopharm is also prepared to consider earlier stage candidates. It develops its products for global registration and maximum commercial potential. The products are out-licensed to pharmaceutical partners for sales and marketing. Besides drug development, Debiopharm Group™ has recently embarked in the field of companion diagnostics with a view to progressing in the area of personalised medicine.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
Debio 1143SMAC mimeticHead & Neck cancerII
Debio 1143SMAC mimeticOvarian cancerII
Debio 1347FGFR inhibitorVarious cancer typesI
Debio 1143SMAC mimeticNon Small Cell Lung Cancer (NSCLC)Preclinical

View additional information on product candidates here »


Recent News Headlines

There are no news items to display